Stevens-Johnson syndrome
- Authors: Olisova O.Y.1, Grabovskaya O.V1, Teplyuk N.P1, Lepekhova A.A1, Ignatiev D.V1, Ignatieva K.V.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 19, No 4 (2016)
- Pages: 216-220
- Section: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/37092
- DOI: https://doi.org/10.18821/1560-9588-2016-19-4-216-220
- ID: 37092
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O. Yu Olisova
I.M. Sechenov First Moscow State Medical UniversityDepartment of Skin and Venereal Diseases n.a. V.A. Rakhmanov Moscow, 119991, Russian Federation
O. V Grabovskaya
I.M. Sechenov First Moscow State Medical UniversityDepartment of Skin and Venereal Diseases n.a. V.A. Rakhmanov Moscow, 119991, Russian Federation
N. P Teplyuk
I.M. Sechenov First Moscow State Medical UniversityDepartment of Skin and Venereal Diseases n.a. V.A. Rakhmanov Moscow, 119991, Russian Federation
A. A Lepekhova
I.M. Sechenov First Moscow State Medical UniversityDepartment of Skin and Venereal Diseases n.a. V.A. Rakhmanov Moscow, 119991, Russian Federation
D. V Ignatiev
I.M. Sechenov First Moscow State Medical UniversityDepartment of Skin and Venereal Diseases n.a. V.A. Rakhmanov Moscow, 119991, Russian Federation
Kseniya V. Ignatieva
I.M. Sechenov First Moscow State Medical University
Email: deleraugo@gmail.com
clinical ordinator of Department of Skin and Venereal Diseases of I.M. Setchenov First Moscow State Medical University Moscow, 119991, Russian Federation
References
- Заславский Д.В., Горланов И.А., Самцов А.В., Хайрутдинов В.Р. Федеральные клинические рекомендации по ведению больных cиндромом Стивенса-Джонсона/токсическим эпидермальным некролизом. М.: Российское общество дерматовенерологов и косметологов; 2013.
- Harr T., French L.E. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet. J. Rare Dis. 2010; 5: 39-50. doi: 10.1186/1750-1172-5-39.
- Miliszewski M.A., Kirchhof M.G., Sikora S., Papp A., Dutz J.P. Stevens-Johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention. Am. J. Med. 2010; 123(3): 22-40.
- Lu N., Rai S.K., Terkeltaub R., Kim S.C., Menendez M.E., Choi H.K. Racial disparities in the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States. Semin. Arthritis. Rheum. 2016. pii: S0049-0172(16)30004-X. doi: 10.1016/j.semarthrit.2016.03.014.
- Chung W.H., Hung S.I. Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergol. Inter. 2010; 59(4): 325-32.
- French L.E. Toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Allergol. Inter. 2006; 55(1): 9-16.
- Ho H.H.F. Diagnosis and management of Stevens-Johnson Syndrome and toxic epidermal necrolysis. HongKong Med. Diary. 2008; 13(10): 17-20.
- Kardaun S.H., Jonkman M.F. Dexamethasone pulse therapy for Stevens-Johnson Syndrome/toxic epidermal necrolysis. Acta Derm. Venereol. 2007; 87(2): 144-8.
- Momin S.B. Review of intravenous immunoglobulin in the treatment of Stevens-Johnson Syndrome and toxic epidermal necrolysis. J. Clin. Aesthet. Dermatol. 2009; 2(2): 51-8.
- Григорьев Д.В. Многоформная экссудативная эритема, синдром Стивенса-Джонсона и синдром Лайелла - современная трактовка проблемы. Русский медицинский журнал. Дерматология. 2013; 21(22): 1073-83. http://www.rmj.ru/articles/dermatologiya/Mnogoformnaya_ekssudativnaya_eritema_sindrom_StivensaDghonsona_i_sindrom_Layella_sovremennaya_traktovka_problemy/#ixzz4G5NNRx8f
Supplementary files
